Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Reconstructive Urology Surgery.

Gregory Schenk is an Urologist in Reston, Virginia. Dr. Schenk is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Schenk is currently accepting new patients.

Inderjit Singh is an Obstetrics and Gynecologist in Falls Church, VA. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Boils, Folliculitis, Carbuncle, Ureteroscopy, and Nephrectomy.

Sekwon Jang is a Hematologist Oncology specialist and an Oncologist in Falls Church, Virginia. Dr. Jang is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Cutaneous T-Cell Lymphoma (CTCL), and Squamous Cell Skin Carcinoma. Dr. Jang is currently accepting new patients.

Wonsock Shin is a primary care provider, practicing in Internal Medicine in Vienna, Virginia. Dr. Shin is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are High Cholesterol, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Dr. Kathleen Sterling is part of the Suburban Hospital’s medical staff and a urologist with Urological Consultants, P.A. Dr. Sterling served as chief resident of the University of Maryland Medical Center urology program. During her training, she performed laboratory research related to overactive bladder. With an undergraduate degree from Vanderbilt University, Dr. Sterling served as a Surface Warfare Officer in the United States Navy, completing two deployments at sea, including one combat mission during Operation Iraqi Freedom. Dr. Sterling treats both men and women. Her expertise includes voiding dysfunction, male and female urinary incontinence and female pelvic floor disorders. Dr. Sterling’s practice also encompasses medical and surgical management of kidney stones, erectile dysfunction and urological cancers. Dr. Sterling sees patients in Bethesda and Germantown, Maryland. For appointments, call 301-530-1700. Dr. Sterling is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Urinary Incontinence, Kidney Stones, and Ureteroscopy.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Raj Manchandani is a Hematologist and an Oncologist in Reston, Virginia. Dr. Manchandani is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Mycosis Fungoides, Anemia, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Manchandani is currently accepting new patients.

Jennifer Young is an Urologist in Reston, Virginia. Dr. Young is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Obstructive Uropathy, Bilateral Hydronephrosis, Hydronephrosis, Prostatectomy, and Ureteroscopy. Dr. Young is currently accepting new patients.

Christine Tran is an Urologist in Reston, Virginia. Dr. Tran is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Urinary Tract Infection in Children, Boils, Kidney Stones, Ureteroscopy, and Nephrectomy. Dr. Tran is currently accepting new patients.

Simon Chung is an Urologist in Fairfax, Virginia. Dr. Chung is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Prostate Cancer, Vasectomy, and Reconstructive Urology Surgery. Dr. Chung is currently accepting new patients.

Edmond Paquette is an Urologist in Falls Church, Virginia. Dr. Paquette is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Paquette is currently accepting new patients.

Robert Clark is a primary care provider, practicing in Internal Medicine in Bethesda,, Maryland. Dr. Clark is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Richter Syndrome, Colonoscopy, and Endoscopy.

Dr. Rosenblum is originally from Mexico City. He received his medical degree from the Anahuac University where he graduated at the top of his class. He then competed for and was awarded a urology residency position at the prestigious National Institute of Medical Sciences in Mexico. He subsequently accepted a fellowship position in urologic oncology at the University of Colorado Health Sciences Center in Denver, where he was involved in multiple research projects relating to urologic cancers–in particular, prostate cancer treatments and prostate cancer chemoprevention. Upon completing his fellowship, Dr. Rosenblum emigrated to the United States and became board eligible by completing his second urology residency at the Washington Hospital Center in Washington, D.C. He is a diplomate of the American Board of Urology. Dr. Rosenblum has been in private practice since 2005. He also volunteers as a consultant for the Montgomery County Cancer Crusade. He has a diverse urologic practice with particular interests in minimally invasive surgery for urologic cancers. Dr. Rosenblum has published multiple journal articles and meeting abstracts, and he has been an invited lecturer both here and abroad. He has received multiple awards and distinctions along the course of his career. Dr. Rosenblum is a member of the American Urological Associationand a Fellow of the American College of Surgeons. When he is not caring for patients, Dr. Rosenblum enjoys spending time with his wife, two small daughters, and his dog, Lucas. Dr. Rosenblum is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Nephrectomy.

Dr. Stephen C. Greco is a radiation oncologist at Sibley Memorial Hospital and the director of the department of radiation oncology at Suburban Hospital. Dr. Greco practices out of Sibley’s Prostate Cancer Multidisciplinary Clinic in Washington, D.C. and Suburban Hospital in Bethesda, MD. Dr. Greco has an expertise in various kinds of cancer, including lung, liver, pancreatic and prostate. He has clinical interests in conformal radiation treatment techniques and prostate cancer treatment, including prostate seed implantation. Dr. Greco earned his undergraduate degree from the University of Virginia and his medical degree from Louisiana State University School of Medicine, where he also completed an internship in internal medicine. Dr. Greco completed his residency in radiation oncology at Baylor College of Medicine. Dr. Greco has been named a Top MD by Consumers’ Checkbook Magazine and was named one of the Top Doctors in the Washington D.C., Baltimore and Washington-Baltimore areas by Castle Connolly in 2012. He is a member of the American Society of Clinical Oncology. Dr. Greco has been involved with a clinical trial for “Radiation and Androgen Ablation for Prostate Cancer.” Dr. Greco was also named the 2015 Best Consulting Physician at Suburban Hospital by Johns Hopkins Medicine Clinical Awards for Physicians and Care Teams. Make A Gift Videos 2015 Best Consulting Physician at Suburban Hospital - Stephen Greco, M.D. Dr. Greco is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Prostatectomy.

Brandi Page, M.D., is an assistant professor of radiation oncology and molecular sciences for Johns Hopkins Radiation Oncology Department at Suburban Hospital and a radiation oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Page has expertise in treating all types of cancer and, for the last several years, has become a highly sought-after specialist in the National Capitol Region (NCR-MD/DC/VA) for her expertise in treating head and neck and brain/central nervous system tumors. In Dr. Page's role with Johns Hopkins she has brought new complex radiotherapy services to the facility and facilitated the team building environment for collaborating practitioners and caregivers in the region. Dr. Page also serves on the Cancer Committee for Sibley and Suburban Hospitals for the American Cancer Society, which brings together multidisciplinary care providers to collaborate on initiatives for continued excellence. She is a teaching faculty member at the Johns Hopkins School of Medicine for medical students, residents and fellows, is the current director of radiation oncology fellowships, initiating and growing the first radiation oncology fellowship at the institution a year after the initiation of the proton center. Dr. Page earned her medical degree at Albany Medical College, completed residency in radiation oncology at the Huntsman Cancer Institute at the University of Utah, and fellowship in translational radiation oncology at Wake Forest University Medical Center, where she earned the Service Excellence in Patient Care Award. At Johns Hopkins she has won awards for clinical excellence nominated by peers many years in a row and a Faculty of the Year award for her teaching efforts. Dr. Page is a member of the American Society of Therapeutic Radiation Oncology, a diplomate of the American Board of Radiology, and a Fellow of the American College of Radiation Oncology. Dr. Page has served on the Board of Directors for Radiating Hope and currently serves on the Board of Directors for Courage Unmasked/911-4-HNC (a Head and Neck Cancer support organization). Dr. Page frequently serves as a sought after reviewer for peer reviewed articles and has served as the Continuing Medical Education Editor for the International Journal of Radiation Oncology Biology Physics (IJROBP). Dr. Page believes the best way to empower patients is with knowledge and partnership and she looks forward to partnering with patients in treating their condition, and helping them successfully get through their treatment and maximize opportunities for a happy healthy life after treatment. Make A Gift LinkedIn https://www.linkedin.com/in/brandi-page-968650b0. Dr. Page is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Brain Tumor, Throat Cancer, Laryngeal Cancer, Glioma, and Gamma Knife Radiosurgery.

Robert Mordkin is an Urologist in Arlington, Virginia. Dr. Mordkin is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Mordkin is currently accepting new patients.

Andrew Joel is an Urologist in Arlington, Virginia. Dr. Joel is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Joel is currently accepting new patients.

Gregory Bernstein is an Urologist in Arlington, Virginia. Dr. Bernstein is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Nephrectomy. Dr. Bernstein is currently accepting new patients.